[{"trial_id":86,"discovery_date":"2021-05-28T12:44:08","title":"Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Estimate the Number of Spinal Cord Lesions Detected With the 3D FGAPSIR Sequence That Were Not Detected With the 3D PSIR Sequence&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Device: MRI&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br&#x2F;&gt;&lt;b&gt;Enrolling by invitation&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04906928?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-28T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":85,"discovery_date":"2021-05-28T12:44:08","title":"Next-Gen MS: Feed-forward PRO Data for MS Research","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    EMD Serono Research &amp; Development Institute, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04907305?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-28T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":84,"discovery_date":"2021-05-28T12:44:08","title":"The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Behavioral: Forced Aerobic Exercise (FE);   Behavioral: Voluntary Aerobic Exercise (VE)&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    The Cleveland Clinic&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04906057?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-28T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":83,"discovery_date":"2021-05-27T12:09:08","title":"Pilot Investigation to Evaluate FlowOx2.0™ for Experimental Treatment of Spasticity","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Spasticity, Muscle;   Pain&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Device: FlowOx™&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Otivio AS;   Haukeland University Hospital&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04904016?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-27T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":82,"discovery_date":"2021-05-26T15:30:08","title":"The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple Sclerosis Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis Relapse&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    IRCCS National Neurological Institute &quot;C. Mondino&quot; Foundation&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04902690?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-26T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":81,"discovery_date":"2021-05-20T11:40:26","title":"Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Siponimod&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04895202?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-20T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":80,"discovery_date":"2021-05-19T11:05:28","title":"Adapting mHealth Technology to Improve Patient Activation","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Spinal Cord Injuries;   Stroke;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Behavioral: Fatigue self-management SMS intervention&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Washington University School of Medicine;   The Foundation for Barnes-Jewish Hospital&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04893590?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":79,"discovery_date":"2021-05-19T11:05:27","title":"Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: blood sample&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Medical University of Graz&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04892134?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":78,"discovery_date":"2021-05-18T10:30:26","title":"Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Other: Technology Supported Task-Oriented Circuit Training;   Other: Home-based Telerehabilitation&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Hacettepe University&lt;br&#x2F;&gt;&lt;b&gt;Active, not recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04891341?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-18T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":77,"discovery_date":"2021-05-17T17:47:26","title":"Holter of Movement in Patients With Multiple Sclerosis in Controlled Environment.","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Device: Actimyo°;   Device: IMU&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Dr. Stéphanie Delstanche;   SYSNAV;   Centre Hospitalier Universitaire de Liège&lt;br&#x2F;&gt;&lt;b&gt;Active, not recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04888689?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-17T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":76,"discovery_date":"2021-05-14T12:06:26","title":"The Effects of Respiratory-based Telerehabilitaion in Patients With MS","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Telerehabilitation;   Compliance, Patient&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: pulmonory based home exercises&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Dr. Anıl Tosun;   Trakya University&lt;br&#x2F;&gt;&lt;b&gt;Enrolling by invitation&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04887051?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-14T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":75,"discovery_date":"2021-05-13T16:26:30","title":"Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Ofatumumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04869358?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-03T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":74,"discovery_date":"2021-05-13T10:18:31","title":"An Examination of Cognitive Fatigue Using Functional Neuroimaging","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis, Relapsing-Remitting&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Zeposia&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Kessler Foundation;   Celgene;   Hackensack Meridian Health;   St. Barnabas Medical Center&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04885894?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-13T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":73,"discovery_date":"2021-05-12T10:42:31","title":"Holter of Movement in Patients With Multiple Sclerosis in Uncontrolled Environment.","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Device: Actimyo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Dr. Stéphanie Delstanche;   SYSNAV;   Centre Hospitalier Universitaire de Liège&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04882891?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-12T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":72,"discovery_date":"2021-05-11T11:06:31","title":"Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Behavioral: B-HIPE (Brief High Impact Preparatory Experience)&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Fondazione Don Carlo Gnocchi Onlus&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04881422?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-11T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":71,"discovery_date":"2021-05-10T12:29:31","title":"Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis, Relapsing-Remitting;   Fatigue&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY];   Drug: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Harvard Medical School;   Gilead Sciences&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04880577?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-10T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":70,"discovery_date":"2021-05-10T12:29:31","title":"Proof-of-concept Study for SAR441344 in Relapsing Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: SAR441344 IV;   Drug: placebo IV;   Drug: SAR441344 SC;   Drug: placebo SC;   Drug: MRI contrast-enhancing preparations&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Sanofi&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04879628?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-10T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":69,"discovery_date":"2021-05-07T11:43:30","title":"Prevention of Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Radiologically Isolated Syndrome;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: Ocrelizumab;   Other: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Yale University;   Genentech, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04877457?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-07T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":68,"discovery_date":"2021-05-07T11:43:30","title":"A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Relapsing Multiple Sclerosis (RMS)&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: Ofatumumab;   Biological: mRNA COVID-19 vaccine;   Drug: interferon or glatiramer acetate&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04878211?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-07T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":67,"discovery_date":"2021-05-06T11:08:31","title":"Sonification Techniques for Gait Training","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Parkinson Disease;   Stroke;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Device: Gait rehabilitation with &quot;sonification&quot;;   Other: Standard gait rehabilitation (without sonification)&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Istituti Clinici Scientifici Maugeri SpA&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04876339?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-06T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":66,"discovery_date":"2021-05-06T11:08:31","title":"EMDR for Depressed People With Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Depression&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Behavioral: Eye Movement Desensitization and Reprocessing - EMDR&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Fondazione Don Carlo Gnocchi Onlus;   EMDR Europe;   Catholic University of the Sacred Heart&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04875832?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-06T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":65,"discovery_date":"2021-05-05T10:42:09","title":"Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Stroke;   Multiple Sclerosis;   Parkinson Disease&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Device: Experimental Group;   Other: Control Group&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    IRCCS San Camillo, Venezia, Italy;   IRCCS San Raffaele;   Istituti Clinici Scientifici Maugeri SpA;   IRCCS National Neurological Institute &quot;C. Mondino&quot; Foundation;   I.R.C.C.S. Fondazione Santa Lucia&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04874051?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-05T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":64,"discovery_date":"2021-05-05T10:42:09","title":"Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes With Suppressive Capacity in MS","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Ocrelizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Dr Recai Turkoglu;   Health Sciences University Istanbul Haydarpaşa Numune Training and Research Hospital&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04874597?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-05T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":63,"discovery_date":"2021-05-05T10:42:09","title":"From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Biological sample collection&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Nantes University Hospital&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04873492?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-05T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":62,"discovery_date":"2021-05-03T11:30:09","title":"Exploring the Immune Response to SARS-CoV-2&#x2F;COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Ofatumumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04869358?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-05-03T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":61,"discovery_date":"2021-04-30T10:48:20","title":"Validation of a Novel Instrument Task for Assessing Upper Limb","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Assessment of Arm and Hand Sensorimotor Functions in Multiple Sclerosis Subjects&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Assessment of the upper limb (VPIT + PPIT)&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Swiss Federal Institute of Technology;   Kliniken Valens&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04868370?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-30T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":60,"discovery_date":"2021-04-29T20:44:18","title":"Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Ocrelizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    NYU Langone Health;   Genentech, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04855617?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-22T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":59,"discovery_date":"2021-04-28T12:01:02","title":"COVID-19 and Multiple Sclerosis Disease Modifying Therapies","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Covid19;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Nottingham University Hospitals NHS Trust&lt;br&#x2F;&gt;&lt;b&gt;Enrolling by invitation&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04863586?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-28T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":58,"discovery_date":"2021-04-27T12:25:02","title":"Validation of the French Adaptation of the MSWDQ-23 Questionnaire","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: questionnaires&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Centre Hospitalier Universitaire de Nice&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04860791?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-27T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":57,"discovery_date":"2021-04-27T12:25:02","title":"Assessment of sNfL Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Diagnostic Test: Brain MRI;   Diagnostic Test: Spinal Cord MRI;   Diagnostic Test: Retinal imaging&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Centre Hospitalier Universitaire de Nīmes;   Institut de Recherches en Biothérapie&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04860947?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-27T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":56,"discovery_date":"2021-04-26T12:49:02","title":"MS Relapses During COVID-19 Pandemic","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Covid19;   Relapsing Remitting Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: No Intervention&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Nottingham University Hospitals NHS Trust&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04858763?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-26T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":55,"discovery_date":"2021-04-23T20:54:01","title":"Effect of Variance on Error Correction During Coupling","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Progressive Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: synchronisation abilities&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Hasselt University;   National MS Center Melsbroek;   Noorderhart Revalidatie &amp; MS&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04856384?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-23T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":54,"discovery_date":"2021-04-23T20:54:01","title":"Running Title: Walking to Music and in Silence on a Treadmill","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Other: Walking with music with synchronisation;   Other: Walking with music without synchronisation;   Other: walking without music&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Hasselt University;   Noorderhart Revalidatie &amp; MS&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04856345?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-23T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":53,"discovery_date":"2021-04-23T20:54:01","title":"Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Relapse Remitting Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Thomas Jefferson University&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04857489?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-23T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":52,"discovery_date":"2021-04-22T20:19:01","title":"Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Gait Disorders, Neurologic;   Motility Disorder;   Cognitive Impairment&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Device: Robotic Exoskeleton Rehabilitation;   Other: Conventional Gait Therapy&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Kessler Foundation;   Kessler Institute for Rehabilitation&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04855825?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-22T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":51,"discovery_date":"2021-04-22T20:19:01","title":"Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis. A Two-center, Prospective Observational Study","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Ocrelizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    NYU Langone Health;   Genentech, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04855617?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-22T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":50,"discovery_date":"2021-04-21T10:57:40","title":"Investigation of the Effects of Selective Exercise Training in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Exercise&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: exercise&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Sanko University&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04853654?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-21T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":49,"discovery_date":"2021-04-19T11:50:37","title":"GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Spinal Cord Injuries;   Multiple Sclerosis;   Parkinsonian Disorders;   Allodynia&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Device: GentleCath™ Air catheter&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    ConvaTec Inc.;   ClinSearch&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04847609?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":48,"discovery_date":"2021-04-19T11:50:37","title":"A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Relapsing Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Other: Ofatumumab;   Other: Covid-19 vaccine&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04847596?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":47,"discovery_date":"2021-04-14T10:53:38","title":"Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Autoimmune or Autoinflammatory Diseases;   HIV;   Multiple Sclerosis;   Solid Tumors or Cancers;   Solid Organ Transplant&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Assistance Publique - Hôpitaux de Paris&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04844489?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-14T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":46,"discovery_date":"2021-04-14T10:53:38","title":"Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Dietary Supplement: Lutein;   Dietary Supplement: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University of Illinois at Urbana-Champaign;   Division of Nutritional Sciences, University of Illinois at Urbana-Champaign&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04843813?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-14T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":45,"discovery_date":"2021-04-14T10:53:38","title":"Covid19 Multiple Sclerosis Vaccine Biospecimen Study","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: SARS-COV-2 mRNA Vaccine&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    NYU Langone Health&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04843774?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-14T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":44,"discovery_date":"2021-04-09T13:11:11","title":"The Effect of Telerehabilitation Based Pilates Training in Multiple Sclerosis Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Telerehabilitation-based Pilates Exercise&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Gazi University&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04838886?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-09T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":43,"discovery_date":"2021-04-09T13:11:11","title":"TELEMS: Feasibility of Remote Patient Visits in MS","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Other: EDSS;   Other: Discussion of symptoms&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Medical University of Vienna&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04838990?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-09T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":42,"discovery_date":"2021-04-08T11:57:29","title":"Comparing the Antibody Response to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab or Natalizumab","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases of the Nervous System;   Nervous System Diseases;   Demyelinating Diseases;   Autoimmune Diseases;   Immune System Diseases;   Pathologic Processes&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Device: Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Dragonfly Research, LLC&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04837651?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-08T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":41,"discovery_date":"2021-04-08T11:57:29","title":"Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMS","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    University Hospital, Strasbourg, France&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04838015?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-08T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":40,"discovery_date":"2021-04-08T11:57:29","title":"Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Covid19&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    St. Barnabas Medical Center&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04834401?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-07T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":39,"discovery_date":"2021-04-08T11:57:29","title":"Impact of Neuropsychological Disorders in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Three dimensional gait analysis with eyetracking&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Lille Catholic University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04837365?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-08T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":38,"discovery_date":"2021-04-08T11:57:29","title":"Therapeutic Adherence of Multiple Sclerosis Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Study of the role of sociocognitive factors&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Lille Catholic University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04837352?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-08T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":37,"discovery_date":"2021-04-06T11:14:24","title":"The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis, Relapsing-Remitting;   Pain, Chronic;   Fatigue Syndrome, Chronic;   Kinesiophobia&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Behavioral: PMR: Progressive Muscle Relaxation;   Behavioral: BRT:Benson Relaxation Technique&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Hacettepe University&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04833673?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-06T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":36,"discovery_date":"2021-04-05T11:38:24","title":"Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Relapsing Remitting Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Natalizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Biogen&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04832399?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-05T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":35,"discovery_date":"2021-04-05T11:38:24","title":"Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Exposure to methylprednisolone during pregnancy&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Jena University Hospital;   Ruhr University of Bochum;   Interdisciplinary Center of Clinical Research of the Medical Faculty Jena;   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04832269?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-04-05T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":34,"discovery_date":"2021-03-30T11:05:24","title":"Imaging Evaluation of Central Nervous Autoimmune Diseases","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    MS (Multiple Sclerosis);   NMO Spectrum Disorder&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Diagnostic Test: MRI&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Qilu Hospital of Shandong University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04822623?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-30T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":33,"discovery_date":"2021-03-30T11:05:24","title":"Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Biological: Mesenchymal Stem Cells (MSC)&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Hadassah Medical Organization&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04823000?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-30T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":32,"discovery_date":"2021-03-29T11:19:37","title":"Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis (MS)&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Procedure: SC MRI;   Other: patient questionnaire&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University Hospital, Basel, Switzerland;   Freie Akademische Gesellschaft Basel&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04819737?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-29T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":31,"discovery_date":"2021-03-29T11:19:36","title":"Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: biological collection&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    University Hospital, Rouen&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04821596?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-29T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":30,"discovery_date":"2021-03-26T13:30:35","title":"Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Urinary Bladder, Neurogenic;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: VESIcare 10Mg Tablet;   Drug: Botox 100 UNT Injection&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Brigitte Schürch;   Centre Hospitalier Universitaire Vaudois&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04819360?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-26T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":29,"discovery_date":"2021-03-26T13:30:35","title":"The Effect of the Arabic Otago Exercise Program on Falls in People With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Otago Exercise Program&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    University of Jordan&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04818008?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-26T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":28,"discovery_date":"2021-03-25T11:16:53","title":"Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Spasticity;   Cerebrovascular Accident;   Multiple Sclerosis;   Traumatic Brain Injury;   Cervical Spinal Cord Injury;   Cerebral Palsy&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: rimabotulinumtoxinB;   Drug: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Supernus Pharmaceuticals, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04815967?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-25T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":27,"discovery_date":"2021-03-19T11:55:20","title":"Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients With Multiple Sclerosis MS-NEUROPLAST","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Cognitive Decline&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Cognitive Training&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Aristotle University Of Thessaloniki;   King Fahad Medical City&lt;br&#x2F;&gt;&lt;b&gt;Active, not recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04806568?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":26,"discovery_date":"2021-03-19T11:55:20","title":"Virtual Reality in Physical Therapy in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Device: Neuroproprioceptive &quot;facilitation and inhibition&quot; in virtual reality;   Other: Neuroproprioceptive &quot;facilitation and inhibition&quot;&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Charles University, Czech Republic&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04807738?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":25,"discovery_date":"2021-03-19T11:55:20","title":"Nature of the Link Between Executive Functions and Theory of Mind in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Theory of Mind&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Lille Catholic University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04806217?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-19T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":24,"discovery_date":"2021-03-18T11:23:53","title":"Emotions in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Diagnostic Test: Carrying out a tests and questionnaires battery&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Lille Catholic University&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04804787?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-18T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":23,"discovery_date":"2021-03-15T14:45:21","title":"Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Clinically Isolated Syndrome&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: blood sample;   Biological: cerebro-spinal fluid&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University Hospital, Bordeaux;   University of Bordeaux&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04798651?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-15T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":22,"discovery_date":"2021-03-15T14:45:21","title":"Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Providence Health &amp; Services&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04796584?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-15T16:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":21,"discovery_date":"2021-03-12T14:58:20","title":"Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Other: Adapted and individualized physical training program;   Other: traditional training program&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Centre Hospitalier Universitaire de Saint Etienne&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04796272?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-12T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":20,"discovery_date":"2021-03-11T12:25:31","title":"Post-COntrast 3D SE T1 Versus Coronal SE T1-WI MRI in Detecting Optic Neuritis (COCON)","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Optic Neuritis;   Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Diagnostic Test: Magnetic Resonance Imaging&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04793087?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-11T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":19,"discovery_date":"2021-03-11T12:25:31","title":"3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Optic Neuritis;   Multiple Sclerosis;   Encephalopathy&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Diagnostic Test: Magnetic Resonance Imaging&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Fondation Ophtalmologique Adolphe de Rothschild&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04792866?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-11T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":18,"discovery_date":"2021-03-11T12:25:30","title":"Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Secondary Progressive Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: BAF312;   Drug: Baseline disease modifying therapies (DMTs)&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04792567?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-11T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":17,"discovery_date":"2021-03-09T14:59:53","title":"Open Label Randomized Multicenter to Assess Efficacy &amp; Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: Ofatumumab;   Drug: First line DMT&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04788615?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-09T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":16,"discovery_date":"2021-03-09T14:59:53","title":"T Cell Profiling in Patients With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: Blood Sample&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Boston Children&#39;s Hospital&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04789551?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-09T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":15,"discovery_date":"2021-03-08T13:43:03","title":"Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis, Relapsing-Remitting;   Sexual Dysfunction&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Behavioral: Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University of Alabama at Birmingham;   National Multiple Sclerosis Society&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04768777?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-24T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":14,"discovery_date":"2021-03-08T13:43:03","title":"miRNA Biomarkers in Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   miRNA;   Epigenetic;   Biomarker&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Genetic: miRNA&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    University of Gaziantep&lt;br&#x2F;&gt;&lt;b&gt;Completed&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04772495?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-26T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":13,"discovery_date":"2021-03-08T13:43:03","title":"Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis (MS)&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Other: At-home natalizumab treated MS patient&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Nantes University Hospital;   Rennes University Hospital&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04777539?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-02T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":12,"discovery_date":"2021-03-08T13:43:03","title":"ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Pediatric Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Behavioral: Physical Activity (PA) Intervention;   Behavioral: Waitlist attention-control&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    The Hospital for Sick Children;   Children&#39;s Hospital of Philadelphia;   University of Alabama at Birmingham;   Queen&#39;s University;   National Multiple Sclerosis Society&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04782466?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-04T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":11,"discovery_date":"2021-03-08T13:43:03","title":"Digital Gait Analysis in the Home Environment of Patients With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    &lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Medical Valley Digital Health Application Center GmbH;   Celgene Corporation;   NeuroSys GmbH;   Fraunhofer Institute for Integrated Circuits IIS;   Portabiles HealthCare Technologies GmbH;   University of Regensburg&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04771858?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-25T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":10,"discovery_date":"2021-03-08T13:43:03","title":"Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    Multiple Sclerosis;   Pathologic Processes;   Sclerosis;   Autoimmune Diseases of the Nervous System;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Behavioral: Standard Exercise Training;   Device: Phoenix Exoskeleton suit&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Sheffield Teaching Hospitals NHS Foundation Trust&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04786821?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-08T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":9,"discovery_date":"2021-03-08T13:43:03","title":"Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Drug: Belimumab;   Drug: Short-course Ocrelizumab;   Drug: Continued Ocrelizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Johns Hopkins University;   GlaxoSmithKline&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04767698?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-23T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":8,"discovery_date":"2021-03-08T13:43:03","title":"The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Dietary Supplement: High Phenolic Extra Virgin Olive Oil&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    University of Cyprus;   World Olive Center for Health;   Ellis-Farm, Eliama Daily Value&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04787497?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-08T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":7,"discovery_date":"2021-03-08T12:17:02","title":"Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Mavenclad®&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04783935?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-05T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":6,"discovery_date":"2021-03-08T12:17:02","title":"Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Drug: Mavenclad®&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04776213?cond&#x3D;Multiple+Sclerosis&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-01T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":5,"discovery_date":"2021-03-02T14:12:09","title":"COVID-19: SARS Vaccination","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    SARS-CoV Infection;   COVID-19;   Allergic Reaction;   Mast Cell Disorder;   Non-atopic&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: Moderna COVID-19 Vaccine;   Biological: Pfizer-BioNTech COVID-19 Vaccine;   Biological: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Rho Federal Systems Division, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04761822?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-21T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":4,"discovery_date":"2021-03-01","title":"Antibody Response to COVID-19 Vaccines in Liver Disease Patients","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Chronic Liver Disease&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: BNT162b2;   Biological: CoronaVac;   Biological: AZD1222&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Humanity &amp; Health Medical Group Limited&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04775069?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-03-01T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":3,"discovery_date":"2021-02-27","title":"Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    SARS-CoV-2 Infection;   COVID-19;   Maternal Immunization&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: BNT162b2;   Other: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    BioNTech SE;   Pfizer&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04754594?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-15T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":2,"discovery_date":"2021-02-27","title":"National Cohort Study of Effectiveness and Safety of SARS-CoV-2&#x2F;COVID-19 Vaccines (ENFORCE)","summary":"&lt;b&gt;Condition&lt;&#x2F;b&gt;:    SARS-CoV Infection&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: COMIRNATY - BioNTech Manufacturing GmbH;   Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH;   Biological: COVID-19 Vaccine AstraZeneca suspension for injection&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Jens D Lundgren, MD;   Ministry of the Interior and Health, Denmark&lt;br&#x2F;&gt;&lt;b&gt;Recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04760132?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-18T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null},{"trial_id":1,"discovery_date":"2021-02-27","title":"COVID-19: SARS Vaccination Reactions","summary":"&lt;b&gt;Conditions&lt;&#x2F;b&gt;:    SARS-CoV Infection;   COVID-19;   Allergic Reaction;   Mast Cell Disorder;   Non-atopic&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Biological: Moderna COVID-19 Vaccine;   Biological: Pfizer-BioNTech COVID-19 Vaccine;   Biological: Placebo&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Rho Federal Systems Division, Inc.&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;","link":"https:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT04761822?term&#x3D;biontech&amp;amp;sfpd_d&#x3D;14&amp;amp;sel_rss&#x3D;new14","published_date":"2021-02-21T17:00:00.000Z","source":"ClinicalTrials.gov","relevant":null,"table_constraints":null}]